ESC Premium Access

The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.

Congress Presentation

About the speaker

Professor Atsushi Kuno

Sapporo Medical University, Sapporo (Japan)
1 presentation
0 follower

5 more presentations in this session

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

Speaker: Doctor N. Raad (New York, US)


Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation

Speaker: Doctor K. Hammer (Regensburg, DE)


Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets

Speaker: Associate Professor N. Tiso (Padova, IT)


BNP signal peptide protects the heart from ischemia-reperfusion injury

Speaker: Professor C. Pemberton (Christchurch, NZ)


Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure

Speaker: Professor B. Assmus (Giessen, DE)


Access the full session

Late Breaking Basic and Translational Science - Cardiac Biology

Speakers: Professor A. Kuno, Doctor N. Raad, Doctor K. Hammer, Associate Professor N. Tiso, Professor C. Pemberton...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb